PTN

PALATIN TECHNOLOGIES INC

Healthcare · Biotechnology

$213.59 sample

-1.27 (-0.59%) 1D

Market cap

$364.7B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-28

Alerts

8

Price$213.59 -10.18% 3M daily closessample

241.94213.59

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28SEC8-K filed: material event
Sep 22INSInsider sell: 10% owner
Sep 17INSInsider sell: Chief Financial Officer
Sep 14INSInsider sell: 10% owner
Sep 04SEC10-Q filed
Aug 28INSInsider buy: Director
Aug 24SEC10-Q filed
Aug 19INSInsider buy: General Counsel

Sign up to see the real PTN record →

Company facts

SEC EDGAR registration

Name: PALATIN TECHNOLOGIES INC
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -22sample, -100 to +100
Reporting currency: USD

Who is positioning in PTN

sample

Insiders: 8 insider transactions over 90 days, net selling, $506.8M
Congress: 2 members traded over 90 days
Institutions · 13F: 22 funds hold $4.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.5B +20.4% y/y

Q4 2024Q3 2026

Inventory$12.6B +11.1% y/y

Q4 2024Q3 2026

Accounts receivable$10.1B +16.0% y/y

Q4 2024Q3 2026

Total debt$24.8B +8.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $248.7B +9.0% 3M
Sample peer B: $48.9B -11.2% 3M
Sample peer C: $339.2B -0.2% 3M
Sample peer D: $64.5B -9.4% 3M
Sample peer E: $132.6B -8.3% 3M